Skip to main content
. 2013 Apr 12;13:35. doi: 10.1186/1471-2377-13-35

Figure 2.

Figure 2

Flow diagram outlying a provisional ‘roadmap’ for conducting a study to determine whether a given biomarker is a suitable surrogate for a clinical measure of disease progression.